L-arginine/Finding
One finding, on its own
A single claim from the graph, with the grade computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases necrotising enterocolitis incidence
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“There was a statistically significant reduction in the risk of developing NEC (any stage) in the arginine group compared with the placebo group [RR 0.24 (95% CI 0.10, 0.61), RD -0.21 (95% CI -0.32, -0.09)].”
Quoted verbatim from Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.. - Study
- meta-analysis
- Population
- preterm neonates given enteral or parenteral arginine supplementation vs placebo or no treatment, pooled from the single eligible trial identified by this review
Effect 0.24 risk ratio, 95% CI 0.1 to 0.61
Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.2007PMID:17636753Permalink
Keep reading
- Everything the graph holds on L-arginine
- Every compound studied against Necrotising enterocolitis incidence
- How to read the grade and the marks
To cite this finding: https://catalystproject.ai/e/01M38THKEDPAC6VY42FAV2N2K5